India Medical Device Technology Market 2026-2035
Description
India Medical Device Technology Market Size, Share & Trends Analysis Report by Device Type (In Vitro Diagnostics Devices, Diagnostic Imaging Devices, Cardiology Devices, Ophthalmology Devices, Orthopedic Devices, and Others) Forecast Period 2026-2035
Industry Overview
India medical device technology market was valued at $11.4 billion in 2025 and is projected to reach $21.7 billion by 2035, growing at a CAGR of 6.6% during the forecast period (2026–2035). The medical device market in India is expanding rapidly, driven by growing healthcare infrastructure, rising patient awareness, and increasing demand for advanced diagnostic and therapeutic solutions. Hospitals and diagnostic centers are progressively adopting high-precision imaging systems, automated laboratory equipment, and minimally invasive devices to enhance clinical outcomes. Rising prevalence of chronic and lifestyle-related diseases, along with an aging population, is further accelerating demand for innovative medical technologies. Government initiatives aimed at improving access to quality healthcare and encouraging domestic manufacturing are also supporting market growth. Additionally, collaborations between global manufacturers and local companies are facilitating the introduction of cutting-edge devices. Collectively, these factors are fostering a dynamic and rapidly evolving medical device landscape in India.
Market Dynamics
Expansion of Advanced Diagnostic Solutions
India’s medical device market is witnessing significant growth in diagnostic technologies as hospitals and laboratories adopt automated analyzers, molecular testing platforms, and point-of-care systems. The increasing prevalence of chronic and infectious diseases is driving demand for faster and more accurate diagnostics. Key global and domestic players are investing in localized production and technology partnerships to meet rising clinical needs. Government programs supporting laboratory modernization and improved healthcare access are further accelerating adoption. Recent trends include the integration of digital reporting and AI-assisted interpretation tools to enhance efficiency and precision. This focus on advanced diagnostics is strengthening the overall clinical decision-making ecosystem in India.
Adoption of Minimally Invasive and Therapeutic Devices
The Indian market is seeing increased uptake of minimally invasive devices across cardiology, orthopedics, and ophthalmology as providers aim to improve patient outcomes and reduce recovery times. Hospitals are investing in robotic-assisted systems, image-guided tools, and advanced implants to support complex procedures. Rising surgical volumes and an expanding middle-class patient base are contributing to steady demand growth. Leading manufacturers are introducing cost-effective and scalable solutions suitable for diverse healthcare settings. Recent trends also highlight collaborations between local and international companies to enhance technology access. These developments are positioning India as a rapidly evolving market for therapeutic and specialty devices.
Market Segmentation
The in vitro diagnostics segment in India is expanding rapidly as healthcare providers focus on early disease detection and efficient monitoring of chronic and infectious conditions. Growth is supported by increasing adoption of automated analyzers, molecular testing platforms, and point-of-care devices in hospitals and diagnostic labs. Key players such as Roche, Abbott, Siemens Healthineers, and Becton Dickinson are strengthening their presence through collaborations and localized manufacturing. Rising healthcare awareness and government initiatives to upgrade lab infrastructure are accelerating market penetration. Recent trends include the integration of AI-assisted interpretation tools and digital reporting systems to enhance accuracy and workflow efficiency. These developments are positioning IVD devices as a critical component of India’s evolving healthcare ecosystem.
Diagnostic Imaging Devices
The diagnostic imaging segment in India is witnessing steady growth driven by rising demand for advanced MRI, CT, ultrasound, and digital X-ray systems. Hospitals and specialty centers are upgrading equipment to support early detection, precise diagnostics, and improved treatment planning. Leading companies such as GE HealthCare, Philips, Siemens Healthineers, and Canon Medical are introducing cost-effective, compact, and energy-efficient solutions suitable for Indian healthcare settings. Increased investment in private and public hospital infrastructure is further boosting adoption rates. Recent trends include cloud-based image storage, tele-radiology solutions, and AI-enabled image analysis to enhance workflow and diagnostic accuracy. Collectively, these factors are supporting sustained growth in the imaging segment across the country.
Market Players Outlook
The major companies operating in the Indian medical device technology market include Medtronic Plc, Abbott Laboratories, Siemens Healthineers, GE Healthcare, and B. Braun Melsungen SE, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
Industry Overview
India medical device technology market was valued at $11.4 billion in 2025 and is projected to reach $21.7 billion by 2035, growing at a CAGR of 6.6% during the forecast period (2026–2035). The medical device market in India is expanding rapidly, driven by growing healthcare infrastructure, rising patient awareness, and increasing demand for advanced diagnostic and therapeutic solutions. Hospitals and diagnostic centers are progressively adopting high-precision imaging systems, automated laboratory equipment, and minimally invasive devices to enhance clinical outcomes. Rising prevalence of chronic and lifestyle-related diseases, along with an aging population, is further accelerating demand for innovative medical technologies. Government initiatives aimed at improving access to quality healthcare and encouraging domestic manufacturing are also supporting market growth. Additionally, collaborations between global manufacturers and local companies are facilitating the introduction of cutting-edge devices. Collectively, these factors are fostering a dynamic and rapidly evolving medical device landscape in India.
Market Dynamics
Expansion of Advanced Diagnostic Solutions
India’s medical device market is witnessing significant growth in diagnostic technologies as hospitals and laboratories adopt automated analyzers, molecular testing platforms, and point-of-care systems. The increasing prevalence of chronic and infectious diseases is driving demand for faster and more accurate diagnostics. Key global and domestic players are investing in localized production and technology partnerships to meet rising clinical needs. Government programs supporting laboratory modernization and improved healthcare access are further accelerating adoption. Recent trends include the integration of digital reporting and AI-assisted interpretation tools to enhance efficiency and precision. This focus on advanced diagnostics is strengthening the overall clinical decision-making ecosystem in India.
Adoption of Minimally Invasive and Therapeutic Devices
The Indian market is seeing increased uptake of minimally invasive devices across cardiology, orthopedics, and ophthalmology as providers aim to improve patient outcomes and reduce recovery times. Hospitals are investing in robotic-assisted systems, image-guided tools, and advanced implants to support complex procedures. Rising surgical volumes and an expanding middle-class patient base are contributing to steady demand growth. Leading manufacturers are introducing cost-effective and scalable solutions suitable for diverse healthcare settings. Recent trends also highlight collaborations between local and international companies to enhance technology access. These developments are positioning India as a rapidly evolving market for therapeutic and specialty devices.
Market Segmentation
- Based on the device type, the market is segmented into in vitro diagnostics devices, diagnostic imaging devices, cardiology devices, ophthalmology devices, orthopedic devices, and others.
The in vitro diagnostics segment in India is expanding rapidly as healthcare providers focus on early disease detection and efficient monitoring of chronic and infectious conditions. Growth is supported by increasing adoption of automated analyzers, molecular testing platforms, and point-of-care devices in hospitals and diagnostic labs. Key players such as Roche, Abbott, Siemens Healthineers, and Becton Dickinson are strengthening their presence through collaborations and localized manufacturing. Rising healthcare awareness and government initiatives to upgrade lab infrastructure are accelerating market penetration. Recent trends include the integration of AI-assisted interpretation tools and digital reporting systems to enhance accuracy and workflow efficiency. These developments are positioning IVD devices as a critical component of India’s evolving healthcare ecosystem.
Diagnostic Imaging Devices
The diagnostic imaging segment in India is witnessing steady growth driven by rising demand for advanced MRI, CT, ultrasound, and digital X-ray systems. Hospitals and specialty centers are upgrading equipment to support early detection, precise diagnostics, and improved treatment planning. Leading companies such as GE HealthCare, Philips, Siemens Healthineers, and Canon Medical are introducing cost-effective, compact, and energy-efficient solutions suitable for Indian healthcare settings. Increased investment in private and public hospital infrastructure is further boosting adoption rates. Recent trends include cloud-based image storage, tele-radiology solutions, and AI-enabled image analysis to enhance workflow and diagnostic accuracy. Collectively, these factors are supporting sustained growth in the imaging segment across the country.
Market Players Outlook
The major companies operating in the Indian medical device technology market include Medtronic Plc, Abbott Laboratories, Siemens Healthineers, GE Healthcare, and B. Braun Melsungen SE, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In March 2025, Wipro GE Healthcare launched Versana Premier R3, an AI-powered, Made-in-India ultrasound system to enhance clinical accuracy, streamline workflows, and improve diagnostics. The system is part of the company’s commitment to the ‘Make in India’ initiative and will be manufactured at its PLI factory in Bengaluru.
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the India medical device technology market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
Table of Contents
103 Pages
- 1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- India Medical Device Technology Market Sales Analysis – Device Type ($ Million)
- 1.1. Research Methodology
- Primary Research Approach
- Secondary Research Approach
- 1.2. Market Snapshot
- 2. Market Overview and Insights
- 2.1. Scope of the Study
- 2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key India Medical Device Technology Industry Trends
- 2.2.2. Market Recommendations
- 3. Market Determinants
- 3.1. Market Drivers
- 3.1.1. Drivers For India Medical Device Technology Market: Impact Analysis
- 3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For India Medical Device Technology Market: Impact Analysis
- 3.3. Market Opportunities
- 3.3.1. Opportunities For India Medical Device Technology Market: Impact Analysis
- 4. Competitive Landscape
- 4.1. Competitive Dashboard – India Medical Device Technology Market Revenue and Share by Manufacturers
- Medical Device Technology Product Comparison Analysis
- 4.2. Key Company Analysis
- 4.2.1. Abbott Laboratories
- 4.2.1.1. Overview
- 4.2.1.2. Product Portfolio
- 4.2.1.3. Financial Analysis
- 4.2.1.4. SWOT Analysis
- 4.2.1.5. Business Strategy
- 4.2.2. B. Braun Melsungen
- 4.2.2.1. Overview
- 4.2.2.2. Product Portfolio
- 4.2.2.3. Financial Analysis
- 4.2.2.4. SWOT Analysis
- 4.2.2.5. Business Strategy
- 4.2.3. GE HealthCare
- 4.2.3.1. Overview
- 4.2.3.2. Product Portfolio
- 4.2.3.3. Financial Analysis
- 4.2.3.4. SWOT Analysis
- 4.2.3.5. Business Strategy
- 4.2.4. Medtronic plc
- 4.2.4.1. Overview
- 4.2.4.2. Product Portfolio
- 4.2.4.3. Financial Analysis
- 4.2.4.4. SWOT Analysis
- 4.2.4.5. Business Strategy
- 4.2.5. Siemens Healthineers
- 4.2.5.1. Overview
- 4.2.5.2. Product Portfolio
- 4.2.5.3. Financial Analysis
- 4.2.5.4. SWOT Analysis
- 4.2.5.5. Business Strategy
- 4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration
- 5. India Medical Device Technology Market Sales Analysis by Device Type ($ Million)
- 5.1. In Vitro Diagnostics Devices
- 5.2. Diagnostic Imaging Devices
- 5.3. Cardiology Devices
- 5.4. Ophthalmology Devices
- 5.5. Orthopedic Devices
- 5.6. Others
- 6. Company Profiles
- 6.1. Abbott Laboratories
- 6.1.1. Quick Facts
- 6.1.2. Company Overview
- 6.1.3. Product Portfolio
- 6.1.4. Business Strategies
- 6.2. B. Braun Melsungen SE
- 6.2.1. Quick Facts
- 6.2.2. Company Overview
- 6.2.3. Product Portfolio
- 6.2.4. Business Strategies
- 6.3. Baxter International Inc.
- 6.3.1. Quick Facts
- 6.3.2. Company Overview
- 6.3.3. Product Portfolio
- 6.3.4. Business Strategies
- 6.4. Becton, Dickinson and Co. (BD)
- 6.4.1. Quick Facts
- 6.4.2. Company Overview
- 6.4.3. Product Portfolio
- 6.4.4. Business Strategies
- 6.5. Boston Scientific Corp.
- 6.5.1. Quick Facts
- 6.5.2. Company Overview
- 6.5.3. Product Portfolio
- 6.5.4. Business Strategies
- 6.6. Cardinal Health Inc.
- 6.6.1. Quick Facts
- 6.6.2. Company Overview
- 6.6.3. Product Portfolio
- 6.6.4. Business Strategies
- 6.7. Danaher Corp.
- 6.7.1. Quick Facts
- 6.7.2. Company Overview
- 6.7.3. Product Portfolio
- 6.7.4. Business Strategies
- 6.8. Edwards Lifesciences Corp.
- 6.8.1. Quick Facts
- 6.8.2. Company Overview
- 6.8.3. Product Portfolio
- 6.8.4. Business Strategies
- 6.9. Fresenius Medical Care AG & Co. KGaA
- 6.9.1. Quick Facts
- 6.9.2. Company Overview
- 6.9.3. Product Portfolio
- 6.9.4. Business Strategies
- 6.10. GE HealthCare
- 6.10.1. Quick Facts
- 6.10.2. Company Overview
- 6.10.3. Product Portfolio
- 6.10.4. Business Strategies
- 6.11. Intuitive Surgical Inc.
- 6.11.1. Quick Facts
- 6.11.2. Company Overview
- 6.11.3. Product Portfolio
- 6.11.4. Business Strategies
- 6.12. Koninklijke Philips N.V. (Philips)
- 6.12.1. Quick Facts
- 6.12.2. Company Overview
- 6.12.3. Product Portfolio
- 6.12.4. Business Strategies
- 6.13. Medline Industries LP
- 6.13.1. Quick Facts
- 6.13.2. Company Overview
- 6.13.3. Product Portfolio
- 6.13.4. Business Strategies
- 6.14. Medtronic plc
- 6.14.1. Quick Facts
- 6.14.2. Company Overview
- 6.14.3. Product Portfolio
- 6.14.4. Business Strategies
- 6.15. Mindray Medical International Ltd.
- 6.15.1. Quick Facts
- 6.15.2. Company Overview
- 6.15.3. Product Portfolio
- 6.15.4. Business Strategies
- 6.16. Olympus Corp.
- 6.16.1. Quick Facts
- 6.16.2. Company Overview
- 6.16.3. Product Portfolio
- 6.16.4. Business Strategies
- 6.17. ResMed Inc.
- 6.17.1. Quick Facts
- 6.17.2. Company Overview
- 6.17.3. Product Portfolio
- 6.17.4. Business Strategies
- 6.18. Siemens Healthineers
- 6.18.1. Quick Facts
- 6.18.2. Company Overview
- 6.18.3. Product Portfolio
- 6.18.4. Business Strategies
- 6.19. Smith & Nephew plc
- 6.19.1. Quick Facts
- 6.19.2. Company Overview
- 6.19.3. Product Portfolio
- 6.19.4. Business Strategies
- 6.20. Steris plc
- 6.20.1. Quick Facts
- 6.20.2. Company Overview
- 6.20.3. Product Portfolio
- 6.20.4. Business Strategies
- 6.21. Stryker Corp.
- 6.21.1. Quick Facts
- 6.21.2. Company Overview
- 6.21.3. Product Portfolio
- 6.21.4. Business Strategies
- 6.22. Terumo Corp.
- 6.22.1. Quick Facts
- 6.22.2. Company Overview
- 6.22.3. Product Portfolio
- 6.22.4. Business Strategies
- 6.23. Zimmer Biomet Holdings Inc.
- 6.23.1. Quick Facts
- 6.23.2. Company Overview
- 6.23.3. Product Portfolio
- 6.23.4. Business Strategies
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

